Old National Bancorp’s Edwards Lifesciences EW Stock Holding History

Old National Bancorp’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.29M	Sell	25,327 -3,710	-13%	-$311K	0.05%	219
2026 Q1	$2.33M	Sell	29,037 -13,318	-31%	-$1.1M	0.04%	233
2025 Q4	$3.61M	Sell	42,355 -16,066	-28%	-$1.32M	0.06%	200
2025 Q3	$4.54M	Sell	58,421 -132,226	-69%	-$10.3M	0.08%	186
2025 Q2	$14.9M	Sell	190,647 -4,495	-2%	-$335K	0.27%	66
2025 Q1	$14.1M	Sell	195,142 -2,001	-1%	-$143K	0.37%	60
2024 Q4	$14.6M	Buy	197,143 +7,066	+4%	+$495K	0.35%	61
2024 Q3	$12.5M	Sell	190,077 -808	-0.4%	-$58.7K	0.29%	77
2024 Q2	$17.6M	Buy	190,885 +5,161	+3%	+$457K	0.42%	50
2024 Q1	$17.7M	Sell	185,724 -726	-0.4%	-$61K	0.42%	53
2023 Q4	$14.2M	Buy	186,450 +2,299	+1%	+$160K	0.37%	59
2023 Q3	$12.8M	Sell	184,151 -4,759	-3%	-$382K	0.37%	64
2023 Q2	$17.8M	Sell	188,910 -4,783	-2%	-$416K	0.51%	42
2023 Q1	$16M	Buy	193,693 +1,106	+0.6%	+$86.9K	0.49%	51
2022 Q4	$14.4M	Sell	192,587 -9,187	-5%	-$708K	0.45%	54
2022 Q3	$16.7M	Buy	201,774 +262	+0.1%	+$25.2K	0.57%	40
2022 Q2	$19.2M	Buy	201,512 +5,209	+3%	+$539K	0.65%	36
2022 Q1	$23.1M	Sell	196,303 -776	-0.4%	-$87.1K	0.85%	25
2021 Q4	$25.5M	Sell	197,079 -7,177	-4%	-$837K	0.91%	24
2021 Q3	$23.1M	Sell	204,256 -634	-0.3%	-$72.4K	0.87%	27
2021 Q2	$21.2M	Buy	204,890 +2,678	+1%	+$252K	0.79%	28
2021 Q1	$16.9M	Buy	202,212 +97	+0%	+$8.2K	0.67%	37
2020 Q4	$18.4M	Sell	202,115 -5,915	-3%	-$491K	0.78%	29
2020 Q3	$16.6M	Buy	208,030 +1,190	+0.6%	+$92.9K	0.8%	29
2020 Q2	$14.3M	Buy	206,840 +737	+0.4%	+$52.4K	0.73%	30
2020 Q1	$13M	Sell	206,103 -1,473	-0.7%	-$106K	0.8%	31
2019 Q4	$16.1M	Sell	207,576 -21,969	-10%	-$1.72M	0.79%	30
2019 Q3	$16.8M	Sell	229,545 -525	-0.2%	-$36.9K	0.85%	30
2019 Q2	$14.2M	Sell	230,070 -13,224	-5%	-$800K	0.72%	35
2019 Q1	$15.5M	Sell	243,294 -13,806	-5%	-$788K	0.81%	31
2018 Q4	$13.1M	Sell	257,100 -2,748	-1%	-$139K	0.73%	30
2018 Q3	$15.1M	Sell	259,848 -3,834	-1%	-$188K	0.74%	28
2018 Q2	$12.8M	Sell	263,682 -4,641	-2%	-$217K	0.66%	39
2018 Q1	$12.5M	Sell	268,323 -18,030	-6%	-$783K	0.66%	42
2017 Q4	$10.8M	Sell	286,353 -14,577	-5%	-$535K	0.56%	52
2017 Q3	$11M	Sell	300,930 -21,636	-7%	-$825K	0.6%	51
2017 Q2	$12.7M	Sell	322,566 -23,940	-7%	-$874K	0.7%	43
2017 Q1	$10.9M	Sell	346,506 -8,877	-2%	-$278K	0.6%	50
2016 Q4	$11.1M	Buy	355,383 +13,515	+4%	+$438K	0.64%	49
2016 Q3	$13.7M	Sell	341,868 -31,104	-8%	-$1.17M	0.79%	39
2016 Q2	$12.4M	Buy	372,972 +53,955	+17%	+$1.85M	0.7%	43
2016 Q1	$9.38M	Buy	+319,017	New	+$8.8M	0.55%	56

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Old National Bancorp's EW Position: Q2 2026 in Review

Old National Bancorp reduced its Edwards Lifesciences (EW) stake by 13% in Q2 2026, selling an estimated $311K and leaving 25,327 shares worth $2.29M. The position accounts for 0.05% of the portfolio, ranked #219.

Old National Bancorp first reported a position in EW in Q1 2016 and has held it in 42 quarters since. The position peaked at $25.5M in Q4 2021. 372 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Old National Bancorp held 25,327 shares of Edwards Lifesciences worth $2.29M as of Q2 2026.
Old National Bancorp sold 3,710 Edwards Lifesciences shares in Q2 2026, an estimated $311K.
Edwards Lifesciences made up 0.05% of Old National Bancorp's portfolio in Q2 2026, its #219 holding.
Old National Bancorp first reported a position in Edwards Lifesciences in Q1 2016 and has held it in 42 quarters since.
Old National Bancorp's Edwards Lifesciences position peaked at $25.5M in Q4 2021.
372 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Old National Bancorp's 13F filing for Q2 2026, filed 15 Jul 2026.